Phase II Trial of SMO/AKT/NF2 Inhibitors in Progressive Meningiomas with SMO/AKT/NF2 Mutations

Type of Cancer
Neuro-Oncology

Site
Hackensack

Sponsor
Alliance

Protocol Number
A071401

To Learn More Call
201-510-0910